Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40


Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients.

Boydell E, Marinari E, Migliorini D, Dietrich PY, Patrikidou A, Dutoit V.

Cancers (Basel). 2019 Apr 2;11(4). pii: E464. doi: 10.3390/cancers11040464.


Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients.

Migliorini D, Dutoit V, Allard M, Hallez NG, Marinari E, Widmer V, Philippin G, Corlazzoli F, Gustave R, Kreutzfeldt M, Blazek N, Wasem J, Hottinger A, Koka A, Momjian S, Lobrinus A, Merkler D, Vargas MI, Walker PR, Patrikidou A, Dietrich PY.

Neuro Oncol. 2019 Feb 12. doi: 10.1093/neuonc/noz040. [Epub ahead of print]


Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic.

Patrikidou A, Maroun P, Patard JJ, Baumert H, Albiges L, Massard C, Loriot Y, Escudier B, Di Palma M, Arfi-Rouche J, Rocher L, Merabet Z, Bossi A, Fizazi K, Blanchard P.

Clin Transl Radiat Oncol. 2018 Jul 6;12:28-33. doi: 10.1016/j.ctro.2018.07.001. eCollection 2018 Aug.


Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO).

Chaigneau L, Patrikidou A, Ray-Coquard I, Valentin T, Linassier C, Bay JO, Moureau Zabotto L, Bompas E, Piperno-Neumann S, Penel N, Alcindor T, Laigre M, Guillemet C, Salas S, Hugli A, Domont J, Sunyach MP, Lecesne A, Blay JY, Nerich V, Isambert N.

Oncologist. 2018 Aug;23(8):948-955. doi: 10.1634/theoncologist.2017-0136. Epub 2018 Jun 22.


Head and neck Merkel cell carcinoma: a retrospective case series and critical literature review with emphasis on treatment and prognosis.

Papadiochos I, Patrikidou A, Patsatsi A, Mangoudi D, Thuau H, Vahtsevanos K.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Feb;125(2):126-139. doi: 10.1016/j.oooo.2017.09.019. Epub 2017 Dec 2. Review.


Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysis.

Blanchard P, Belkhir F, Temam S, El Khoury C, De Felice F, Casiraghi O, Patrikidou A, Mirghani H, Levy A, Even C, Gorphe P, Nguyen F, Janot F, Tao Y.

Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1683-1690. doi: 10.1007/s00405-016-4419-1. Epub 2016 Dec 8.


Key messages from the BFR14 trial of the French Sarcoma Group.

Patrikidou A, Le Cesne A.

Future Oncol. 2017 Feb;13(3):273-284. doi: 10.2217/fon-2016-0409. Epub 2016 Sep 14. Review.


Early PSA response is an independent prognostic factor in patients with metastatic castration-resistant prostate cancer treated with next-generation androgen pathway inhibitors.

Fuerea A, Baciarello G, Patrikidou A, Albigès L, Massard C, Di Palma M, Escudier B, Fizazi K, Loriot Y.

Eur J Cancer. 2016 Jul;61:44-51. doi: 10.1016/j.ejca.2016.03.070. Epub 2016 May 3.


What role does the general practitioner in France play among cancer patients during the initial treatment phase with intravenous chemotherapy? A qualitative study.

Coindard G, Barrière J, Vega A, Patrikidou A, Saldanha-Gomes C, Arnould P, Combessie P, Ourabah R.

Eur J Gen Pract. 2016 Jun;22(2):96-102. doi: 10.3109/13814788.2015.1126821. Epub 2016 Jan 22.


Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.

Patrikidou A, Domont J, Chabaud S, Ray-Coquard I, Coindre JM, Bui-Nguyen B, Adenis A, Rios M, Bertucci F, Duffaud F, Chevreau C, Cupissol D, Pérol D, Emile JF, Blay JY, Le Cesne A; French Sarcoma Group.

Eur J Cancer. 2016 Jan;52:173-80. doi: 10.1016/j.ejca.2015.10.069. Epub 2015 Dec 11.


Introducing Cytology-Based Theranostics in Oral Squamous Cell Carcinoma: A Pilot Program.

Patrikidou A, Valeri RM, Kitikidou K, Destouni C, Vahtsevanos K.

Pathol Oncol Res. 2016 Apr;22(2):401-11. doi: 10.1007/s12253-015-0017-6. Epub 2015 Nov 18.


Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer.

Loriot Y, Eymard JC, Patrikidou A, Ileana E, Massard C, Albiges L, Di Palma M, Escudier B, Fizazi K.

Eur J Cancer. 2015 Sep;51(14):1946-52. doi: 10.1016/j.ejca.2015.06.128. Epub 2015 Jul 21.


Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome.

Patrikidou A, Brureau L, Casenave J, Albiges L, Di Palma M, Patard JJ, Baumert H, Blanchard P, Bossi A, Kitikidou K, Massard C, Fizazi K, Blanchet P, Loriot Y.

Urol Oncol. 2015 May;33(5):202.e9-17. doi: 10.1016/j.urolonc.2015.01.022. Epub 2015 Mar 5.


Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies.

Patrikidou A, Sinapi I, Regnault H, Fayard F, Bouattour M, Fartoux L, Faivre S, Malka D, Ducreux M, Boige V.

Invest New Drugs. 2014 Oct;32(5):1028-35. doi: 10.1007/s10637-014-0100-y. Epub 2014 Apr 22.


Quality of life in breast cancer patients with bisphosphonate-related osteonecrosis of the jaws and patients with head and neck cancer: a comparative study using the EORTC QLQ-C30 and QLQ-HN35 questionnaires.

Kyrgidis A, Triaridis S, Kontos K, Patrikidou A, Andreadis C, Constantinidis J, Vahtsevanos K, Antoniades K.

Anticancer Res. 2012 Aug;32(8):3527-34.


Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells.

Patrikidou A, Vlachostergios PJ, Voutsadakis IA, Hatzidaki E, Valeri RM, Destouni C, Apostolou E, Papandreou CN.

Cancer Cell Int. 2012 Jun 20;12(1):31. doi: 10.1186/1475-2867-12-31.


Expression of neutral endopeptidase, endothelin-1, and nuclear factor kappa B in prostate cancer: interrelations and associations with prostate-specific antigen recurrence after radical prostatectomy.

Vlachostergios PJ, Karasavvidou F, Kakkas G, Moutzouris G, Patrikidou A, Voutsadakis IA, Daliani DD, Zintzaras E, Melekos MD, Papandreou CN.

Prostate Cancer. 2012;2012:452795. doi: 10.1155/2012/452795. Epub 2012 May 15.


Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.

Tsapakidis K, Vlachostergios PJ, Voutsadakis IA, Befani CD, Patrikidou A, Hatzidaki E, Daliani DD, Moutzouris G, Liakos P, Papandreou CN.

Int J Urol. 2012 Jun;19(6):565-74. doi: 10.1111/j.1442-2042.2012.02967.x. Epub 2012 Feb 10.


Baseline plasma levels of interleukin-8 in stage IV non-small-cell lung cancer patients: relationship with nutritional status and prognosis.

Gioulbasanis I, Patrikidou A, Kitikidou K, Papadimitriou K, Vlachostergios PJ, Tsatsanis C, Margioris AN, Papandreou CN, Mavroudis D, Georgoulias V.

Nutr Cancer. 2012;64(1):41-7. doi: 10.1080/01635581.2012.630157. Epub 2011 Nov 18.


Metastasis of a ductal breast carcinoma to the buccal mucosa of the mandible with tooth involvement.

Kechagias N, Ntomouchtsis A, Patrikidou A, Christoforidou B, Andreadis C, Vahtsevanos K.

Oral Maxillofac Surg. 2012 Dec;16(4):377-81. doi: 10.1007/s10006-011-0300-y. Epub 2011 Nov 15.


Supplemental Content

Loading ...
Support Center